Transplantation of Neuronal-Primed Human Bone Marrow Mesenchymal Stem Cells in Hemiparkinsonian Rodents

Bone marrow-derived human mesenchymal stem cells (hMSCs) have shown promise in in vitro neuronal differentiation and in cellular therapy for neurodegenerative disorders, including Parkinson' disease. However, the effects of intracerebral transplantation are not well defined, and studies do not agreed on the optimal neuronal differentiation method. Here, we investigated three growth factor-based neuronal differentiation procedures (using FGF-2/EGF/PDGF/SHH/FGF-8/GDNF), and found all to be capable of eliciting an immature neural phenotype, in terms of cell morphology and gene/protein expression. The neuronal-priming (FGF-2/EGF) method induced neurosphere-like formation and the highest NES and NR4A2 expression by hMSCs. Transplantation of undifferentiated and neuronal-primed hMSCs into the striatum and substantia nigra of 6-OHDA-lesioned hemiparkinsonian rats revealed transient graft survival of 7 days, despite the reported immunosuppressive properties of MSCs and cyclosporine-immunosuppression of rats. Neither differentiation of hMSCs nor induction of host neurogenesis was observed at injection sites, and hMSCs continued producing mesodermal fibronectin. Strategies for improving engraftment and differentiation post-transplantation, such as prior in vitro neuronal-priming, nigral and striatal grafting, and co-transplantation of olfactory ensheathing cells that promote neural regeneration, were unable to provide advantages. Innate inflammatory responses (Iba-1-positive microglia/macrophage and GFAP-positive astrocyte activation and accumulation) were detected around grafts within 7 days. Our findings indicate that growth factor-based methods allow hMSC differentiation toward immature neuronal-like cells, and contrary to previous reports, only transient survival and engraftment of hMSCs occurs following transplantation in immunosuppressed hemiparkinsonian rats. In addition, suppression of host innate inflammatory responses may be a key factor for improving hMSC survival and engraftment.

[1]  Yan Zhou,et al.  Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton’s Jelly to Dopamine Neurons Mediated by the Lmx1a and Neurturin In Vitro: Potential Therapeutic Application for Parkinson’s Disease in a Rhesus Monkey Model , 2013, PloS one.

[2]  A. Mackay-Sim,et al.  Effects of human OEC-derived cell transplants in rodent spinal cord contusion injury , 2010, Brain Research.

[3]  G. Nappi,et al.  Transplantation of Undifferentiated Human Mesenchymal Stem Cells Protects against 6-Hydroxydopamine Neurotoxicity in the Rat , 2010, Cell transplantation.

[4]  K. Nozaki,et al.  Committed Neural Progenitor Cells Derived from Genetically Modified Bone Marrow Stromal Cells Ameliorate Deficits in a Rat Model of Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Geeta Ravindran,et al.  Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease , 2009, Cell biology international.

[6]  J. Borneman,et al.  Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease , 2009, Journal of Neuroinflammation.

[7]  N. Roy,et al.  Enhanced survival and function of neural stem cells‐derived dopaminergic neurons under influence of olfactory ensheathing cells in parkinsonian rats , 2009, Journal of neurochemistry.

[8]  C. Verfaillie,et al.  Erratum:Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001; 98:2615-2625 , 2009 .

[9]  E. Melamed,et al.  Induction of Adult Human Bone Marrow Mesenchymal Stromal Cells into Functional Astrocyte-Like Cells: Potential for Restorative Treatment in Parkinson’s Disease , 2009, Journal of Molecular Neuroscience.

[10]  G. Raisman,et al.  Regeneration of nigrostriatal dopaminergic axons after transplantation of olfactory ensheathing cells and fibroblasts prevents fibrotic scar formation at the lesion site , 2008, Journal of neuroscience research.

[11]  D. Ma,et al.  Long-term serial passage and neuronal differentiation capability of human bone marrow mesenchymal stem cells. , 2008, Stem cells and development.

[12]  E. Melamed,et al.  Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. , 2008, Stem cells and development.

[13]  D. Guilloteau,et al.  Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease , 2008, Neurochemistry International.

[14]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[15]  P. Martiat,et al.  Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells , 2008, BMC Genomics.

[16]  Alain Dagher,et al.  Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years , 2008, Nature Medicine.

[17]  G. A. Limb,et al.  Chondroitin Sulfate Proteoglycans and Microglia Prevent Migration and Integration of Grafted Müller Stem Cells into Degenerating Retina , 2008, Stem cells.

[18]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[19]  P. Rameshwar,et al.  Specification of a Dopaminergic Phenotype from Adult Human Mesenchymal Stem Cells , 2007, Stem cells.

[20]  Steven J. Greco,et al.  An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. , 2007, Stem cells and development.

[21]  Steven J. Greco,et al.  Enhancing Effect of IL-1α on Neurogenesis from Adult Human Mesenchymal Stem Cells: Implication for Inflammatory Mediators in Regenerative Medicine1 , 2007, The Journal of Immunology.

[22]  A. Nauta,et al.  Modulation of Immune Responses by Mesenchymal Stem Cells , 2007, Annals of the New York Academy of Sciences.

[23]  E. Melamed,et al.  Dopaminergic differentiation of human mesenchymal stem cells—Utilization of bioassay for tyrosine hydroxylase expression , 2007, Neuroscience Letters.

[24]  S. Barnett,et al.  Implantation of pure cultured olfactory ensheathing cells in an animal model of parkinsonism , 2007, Acta Neurochirurgica.

[25]  E. Melamed,et al.  Docosahexaenoic acid and arachidonic acid are fundamental supplements for the induction of neuronal differentiation Published, JLR Papers in Press, December 21, 2006. , 2007, Journal of Lipid Research.

[26]  I. Black,et al.  Marrow Stromal Cells Transplanted to the Adult Brain Are Rejected by an Inflammatory Response and Transfer Donor Labels to Host Neurons and Glia , 2006, Stem cells.

[27]  L. Iacovitti,et al.  Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease , 2006, Brain Research.

[28]  A. Storch,et al.  Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols , 2006, Journal of neuroscience research.

[29]  I. Black,et al.  Adult rat bone marrow stromal cells express genes associated with dopamine neurons. , 2006, Biochemical and biophysical research communications.

[30]  S. Busfield,et al.  Olfactory ensheathing cells: characteristics, genetic engineering, and therapeutic potential. , 2006, Journal of neurotrauma.

[31]  J. García-Verdugo,et al.  Thymidine Analogs Are Transferred from Prelabeled Donor to Host Cells in the Central Nervous System After Transplantation: A Word of Caution , 2006, Stem cells.

[32]  E. Melamed,et al.  Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents , 2006, Neuroscience Letters.

[33]  M. Ko,et al.  Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton's Jelly to Dopaminergic Neurons In Vitro: Potential Therapeutic Application for Parkinsonism , 2006, Stem cells.

[34]  Lars Olson,et al.  Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions. , 2005, Brain : a journal of neurology.

[35]  P. Sonego,et al.  Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray , 2005, Journal of Cell Science.

[36]  Renuka Rao,et al.  Cytokine‐induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell‐free condition , 2005, Development, growth & differentiation.

[37]  O. Ringdén,et al.  Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[38]  Susan C Barnett,et al.  Olfactory ensheathing cells: their role in central nervous system repair. , 2005, The international journal of biochemistry & cell biology.

[39]  Steven J. Greco,et al.  Neurons Derived From Human Mesenchymal Stem Cells Show Synaptic Transmission and Can Be Induced to Produce the Neurotransmitter Substance P by Interleukin‐1α , 2005, Stem cells.

[40]  A. Mackay-Sim.  Olfactory ensheathing cells and spinal cord repair. , 2005, The Keio journal of medicine.

[41]  H. Meng,et al.  Differentiation of mesenchymal stem cells into dopaminergic neuron-like cells in vitro. , 2005, Biomedical and environmental sciences : BES.

[42]  E. Caterson,et al.  Transient differentiation of adult human bone marrow cells into neuron-like cells in culture: development of morphological and biochemical traits is mediated by different molecular mechanisms. , 2004, Stem cells and development.

[43]  Scott A Noggle,et al.  Differentiation of Human Embryonic Stem Cells to Dopaminergic Neurons in Serum‐Free Suspension Culture , 2004, Stem cells.

[44]  J. Schulz.  Neuronal pathology in Parkinson’s disease , 2004, Cell and Tissue Research.

[45]  H. Lerche,et al.  Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells , 2004, Journal of Cell Science.

[46]  J. Schulz,et al.  Cellular pathology of Parkinson’s disease: astrocytes, microglia and inflammation , 2004, Cell and Tissue Research.

[47]  P. Seth,et al.  Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells , 2004, Neurobiology of Disease.

[48]  Mari Dezawa,et al.  Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. , 2004, The Journal of clinical investigation.

[49]  I. Black,et al.  Adult Bone Marrow Stromal Cells in the Embryonic Brain: Engraftment, Migration, Differentiation, and Long-Term Survival , 2004, The Journal of Neuroscience.

[50]  A. Mackay-Sim,et al.  Neurotrophin 3 promotes purification and proliferation of olfactory ensheathing cells from human nose , 2004, Glia.

[51]  D. Henderson,et al.  Neuroectodermal differentiation from mouse multipotent adult progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  I. Black,et al.  Marrow Stromal Cells, Mitosis, and Neuronal Differentiation: Stem Cell and Precursor Functions , 2003, Stem cells.

[53]  S. Gronthos,et al.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow , 2003, Journal of Cell Science.

[54]  Elizabeth Simpson,et al.  Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.

[55]  O. Ringdén,et al.  Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex , 2003, Scandinavian journal of immunology.

[56]  R. McKay,et al.  Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease , 2002, Nature.

[57]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[58]  Bruce G. Jenkins,et al.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Chopp,et al.  Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease , 2001, Neuroscience Letters.

[60]  H. Widner,et al.  Porcine Neural Xenografts in Rats and Mice: Donor Tissue Development and Characteristics of Rejection , 2001, Experimental Neurology.

[61]  C. Verfaillie,et al.  Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. , 2001, Blood.

[62]  M. Chopp,et al.  Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats , 2001, Journal of the Neurological Sciences.

[63]  M. Chuah,et al.  Cultured olfactory ensheathing cells express nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. , 2001, Brain research. Molecular brain research.

[64]  I. Fischer,et al.  In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. , 2001, Biochemical and biophysical research communications.

[65]  M. Pipitone,et al.  Neurotrophic and migratory properties of an olfactory ensheathing cell line , 2001, Glia.

[66]  A. Mackay-Sim,et al.  Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats , 2001, Brain Research.

[67]  I. Black,et al.  Adult rat and human bone marrow stromal cells differentiate into neurons , 2000, Journal of neuroscience research.

[68]  W. Janssen,et al.  Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.

[69]  E. Jauniaux,et al.  Human Neural Precursor Cells Express Low Levels of Telomerase in Vitro and Show Diminishing Cell Proliferation with Extensive Axonal Outgrowth following Transplantation , 2000, Experimental Neurology.

[70]  R. McKay,et al.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells , 2000, Nature Biotechnology.

[71]  R. Barker,et al.  A Role for Complement in the Rejection of Porcine Ventral Mesencephalic Xenografts in a Rat Model of Parkinson's Disease , 2000, The Journal of Neuroscience.

[72]  Ornella Rimoldi,et al.  Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient , 1999, Nature Neuroscience.

[73]  O. Korsgren,et al.  Discordant neural tissue xenografts survive longer in immunoglobulin deficient mice. , 1999, Transplantation.

[74]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[75]  R. McKay,et al.  Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats , 1998, Nature Neuroscience.

[76]  Y. Fukuuchi,et al.  Microglia-specific localisation of a novel calcium binding protein, Iba1. , 1998, Brain research. Molecular brain research.

[77]  D. Prockop,et al.  Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[78]  S. Dunnett,et al.  Survival and Differentiation of Rat and Human Epidermal Growth Factor-Responsive Precursor Cells Following Grafting into the Lesioned Adult Central Nervous System , 1996, Experimental Neurology.

[79]  O. Korsgren,et al.  THE MAIN INFILTRATING CELL IN XENOGRAFT REJECTION IS A CD4+ MACROPHAGE AND NOT A T LYMPHOCYTE , 1995, Transplantation.

[80]  D. Turner,et al.  Reactive astrocytes express the embryonic intermediate neurofilament nestin. , 1994, Neuroreport.

[81]  M. Nieto‐Sampedro,et al.  Glial cells from adult rat olfactory bulb: Immunocytochemical properties of pure cultures of ensheathing cells , 1992, Neuroscience.

[82]  L. Olson,et al.  Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation , 1986, Neuroscience Letters.

[83]  J. Borel,et al.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals. , 1977, Immunology.

[84]  E. Melamed,et al.  Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. , 2008, Cytotherapy.

[85]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.

[86]  A. Björklund,et al.  Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease , 2004, Experimental Brain Research.

[87]  Phil M E Waite,et al.  Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. , 2002, Brain : a journal of neurology.

[88]  R. Doucette.  Glial influences on axonal growth in the primary olfactory system , 1990, Glia.

[89]  M. Graeber,et al.  Functional plasticity of microglia: A review , 1988, Glia.

[90]  Robert C. Wolpert,et al.  A Review of the , 1985 .